Biogened S.A. (WSE:BGD)

Poland flag Poland · Delayed Price · Currency is PLN
21.60
0.00 (0.00%)
At close: Dec 11, 2025
13.68%
Market Cap53.06M
Revenue (ttm)115.12M
Net Income (ttm)5.73M
Shares Out2.46M
EPS (ttm)2.33
PE Ratio9.25
Forward PEn/a
Dividend0.50 (2.31%)
Ex-Dividend DateSep 11, 2025
Volume1
Average Volume49
Open21.60
Previous Close21.60
Day's Range21.60 - 21.60
52-Week Range19.50 - 32.80
Beta0.21
RSI43.99
Earnings DateFeb 13, 2026

About Biogened

Biogened S.A. develops, produces, and distributes pharmaceutical products in Poland. The company offers dermo-cosmetics under the Dermedic brand; and thermal water. It also exports its products. The company was incorporated in 2007 and is headquartered in Lódz, Poland. [Read more]

Industry Pharmaceutical Preparations
Founded 2007
Employees 227
Stock Exchange Warsaw Stock Exchange
Ticker Symbol BGD
Full Company Profile

Financial Performance

In 2024, Biogened's revenue was 110.93 million, an increase of 16.09% compared to the previous year's 95.56 million. Earnings were 5.82 million, an increase of 14.22%.

Financial Statements

News

There is no news available yet.